Literature DB >> 14998849

Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.

L Rubbia-Brandt1, V Audard, P Sartoretti, A D Roth, C Brezault, M Le Charpentier, B Dousset, P Morel, O Soubrane, S Chaussade, G Mentha, B Terris.   

Abstract

BACKGROUND: In advanced metastatic colorectal adenocarcinoma, the addition of a neo-adjuvant systemic treatment to surgery might translate into a survival advantage, although this is yet to be confirmed by ongoing randomized trials. The objective of this study was to assess the effects of preoperative systemic chemotherapy on the morphology of non-tumoral liver. PATIENTS AND METHODS: A large series of surgically resected liver metastases (n=153) was selected. Light microscopy, electron microscopy, and immunohistochemistry using antibodies against endothelial cells (CD31) and hepatic stellate cells (alpha-SM actin, CRBP-1) were performed to identify sinusoidal wall integrity.
RESULTS: We found that 44 (51%) of the 87 post-chemotherapic liver resection specimens had sinusoidal dilatation and hemorrhage, related to rupture of the sinusoidal barrier. In contrast, the 66 livers treated by surgery alone remained normal. In 21 out of the 44 post-chemotherapy patients (48%), perisinusoidal and veno-occlusive fibrosis also developed. Sinusoidal injury persisted several months after end of chemotherapy, and fibrosis may progress. Development of lesions was strongly correlated to the use of oxaliplatin; 34 out of 43 patients (78%) treated with this drug showed striking sinusoidal alterations.
CONCLUSIONS: Systemic neo-adjuvant chemotherapy in metastatic colorectal cancer frequently causes morphological lesions involving hepatic microvasculature. Sinusoidal obstruction, complicated by perisinusoidal fibrosis and veno-occlusive lesion of the non-tumoral liver revealed by this study, should be included in the list of the adverse side-effects of colorectal systemic chemotherapy, in particular related to the use of oxaliplatin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14998849     DOI: 10.1093/annonc/mdh095

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  270 in total

Review 1.  The surgical treatment of hepatic metastases in colorectal carcinoma.

Authors:  Ulf Peter Neumann; Daniel Seehofer; Peter Neuhaus
Journal:  Dtsch Arztebl Int       Date:  2010-05-14       Impact factor: 5.594

2.  Preoperative bevacizumab and surgery for colorectal liver metastases: a propensity score analysis.

Authors:  Damien Bergeat; Michel Rayar; Yann Mouchel; Aude Merdrignac; Bernard Meunier; Astrid Lièvre; Karim Boudjema; Laurent Sulpice
Journal:  Langenbecks Arch Surg       Date:  2017-01-13       Impact factor: 3.445

3.  Kinetic Changes in Liver Parenchyma After Preoperative Chemotherapy for Patients with Colorectal Liver Metastases.

Authors:  Keigo Tani; Junichi Shindoh; Takeshi Takamoto; Junji Shibahara; Yujiro Nishioka; Takuya Hashimoto; Yoshihiro Sakamoto; Kiyoshi Hasegawa; Masatoshi Makuuchi; Norihiro Kokudo
Journal:  J Gastrointest Surg       Date:  2017-01-12       Impact factor: 3.452

4.  Noninvasive assessment of hepatic sinusoidal obstructive syndrome using acoustic radiation force impulse elastography imaging: A proof-of-concept study in rat models.

Authors:  So Hyun Park; Seung Soo Lee; Ji-Youn Sung; Kiyong Na; Hyoung Jung Kim; So Yeon Kim; Beom Jin Park; Jae Ho Byun
Journal:  Eur Radiol       Date:  2017-12-07       Impact factor: 5.315

Review 5.  The effects of cancer chemotherapy on liver imaging.

Authors:  Philip J A Robinson
Journal:  Eur Radiol       Date:  2009-02-24       Impact factor: 5.315

6.  Multi-institutional phase II study on the feasibility of liver resection following preoperative mFOLFOX6 therapy for resectable liver metastases from colorectal cancers.

Authors:  Satoshi Nagayama; Suguru Hasegawa; Koya Hida; Kenji Kawada; Etsuro Hatano; Kojiro Nakamura; Satoru Seo; Kojiro Taura; Kentaro Yasuchika; Takashi Matsuo; Masazumi Zaima; Akiyoshi Kanazawa; Hiroaki Terajima; Masaharu Tada; Yukihito Adachi; Ryuta Nishitai; Dai Manaka; Tsunehiro Yoshimura; Koji Doi; Takahiro Horimatsu; Akira Mitsuyoshi; Kenichi Yoshimura; Miyuki Niimi; Shigemi Matsumoto; Yoshiharu Sakai; Shinji Uemoto
Journal:  Int J Clin Oncol       Date:  2016-10-17       Impact factor: 3.402

7.  Computed Tomography Image Texture: A Noninvasive Prognostic Marker of Hepatic Recurrence After Hepatectomy for Metastatic Colorectal Cancer.

Authors:  Amber L Simpson; Alexandre Doussot; John M Creasy; Lauryn B Adams; Peter J Allen; Ronald P DeMatteo; Mithat Gönen; Nancy E Kemeny; T Peter Kingham; Jinru Shia; William R Jarnagin; Richard K G Do; Michael I D'Angelica
Journal:  Ann Surg Oncol       Date:  2017-05-30       Impact factor: 5.344

8.  Efficacy and safety of oxaliplatin, bevacizumab and oral S-1 for advanced recurrent colorectal cancer.

Authors:  Shuji Suzuki; Jiro Shimazaki; Keiichi Morishita; Nobusada Koike; Nobuhiko Harada; Tsuneo Hayashi; Mamoru Suzuki
Journal:  Mol Clin Oncol       Date:  2016-08-04

Review 9.  Drug-induced steatohepatitis.

Authors:  Vaishali Patel; Arun J Sanyal
Journal:  Clin Liver Dis       Date:  2013-09-04       Impact factor: 6.126

10.  Safety and outcomes following resection of colorectal liver metastases in the era of current perioperative chemotherapy.

Authors:  Ilia Gur; Brian S Diggs; Jesse A Wagner; Gina M Vaccaro; Charles D Lopez; Brett C Sheppard; Susan L Orloff; Kevin G Billingsley
Journal:  J Gastrointest Surg       Date:  2013-10-04       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.